Institutional investors purchased a net $3.3 million shares of NVO during the quarter ended June 2017 and now own 8.08% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FISHER ASSET MANAGEMENT LLC Bought 1.3 Million shares of Novo Nordisk
FOLKETRYGDFONDET Bought 803.6 Thousand shares of Novo Nordisk
RIVER ROAD ASSET MANAGEMENT LLC Bought 563.7 Thousand shares of Novo Nordisk